These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29252093)

  • 41. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
    Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
    Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
    Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database.
    Seto Y; Tanaka E; Inoue E; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2011 Dec; 21(6):579-93. PubMed ID: 21424533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis.
    Park HJ; Park MC; Park YB; Lee SK; Lee SW
    Rheumatol Int; 2014 Jun; 34(6):833-40. PubMed ID: 24362788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
    Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB
    Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of MTHFR C677T polymorphism on methotrexate monotherapy discontinuation in rheumatoid arthritis patients: results from the GAPAID European project.
    Uribarri M; Ruiz-Larrañaga O; Arteta D; Hernández L; Alcaro MC; Martínez A; Escorza-Treviño S; Estonba A; Migliorini P; Czirják L; del Amo J
    Clin Exp Rheumatol; 2015; 33(5):699-705. PubMed ID: 26314492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis.
    Huang J; Fan H; Qiu Q; Liu K; Lv S; Li J; Yang H; Shu X; Xu Y; Lu X; Lu C; Zhang Y; Xiao C
    Ther Adv Chronic Dis; 2020; 11():2040622320916026. PubMed ID: 32426102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
    Osuga T; Ikura Y; Kadota C; Hirano S; Iwai Y; Hayakumo T
    Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
    Dubey L; Chatterjee S; Ghosh A
    Indian J Pharmacol; 2016; 48(5):591-594. PubMed ID: 27721549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
    Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
    Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane-Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population.
    Lv S; Fan H; Yang H; Huang J; Li J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Lv C; Kong X; Xiao C
    J Clin Pharmacol; 2019 Nov; 59(11):1471-1476. PubMed ID: 31099054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphism in Organic Anion-Transporting Polypeptide Gene Related to Methotrexate Response in Rheumatoid Arthritis Treatment.
    Takahashi K; Nakamura H; Watanabe A; Majima T; Koiwa M; Kamada T; Takai S
    J Nippon Med Sch; 2019; 86(3):149-158. PubMed ID: 31292326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis.
    Moreno-Otero R; García-Buey L; García-Sanchez A; Trapero-Marugán M
    Curr Drug Saf; 2011 Jul; 6(3):197-200. PubMed ID: 22122395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate.
    Kotrych D; Dziedziejko V; Safranow K; Pawlik A
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3037-40. PubMed ID: 26367725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.
    Willkens RF; Stablein D
    J Rheumatol Suppl; 1996 Mar; 44():64-8. PubMed ID: 8833056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
    Kato T; Hamada A; Mori S; Saito H
    Drug Metab Pharmacokinet; 2012; 27(2):192-9. PubMed ID: 22104130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients.
    Eektimmerman F; Swen JJ; den Broeder AA; Hazes JMW; Kurreeman FS; Verstappen SMM; Nair N; Pawlik A; Nurmohamed MT; Dolžan V; Böhringer S; Allaart CF; Guchelaar HJ
    Clin Pharmacol Ther; 2023 Apr; 113(4):916-923. PubMed ID: 36708065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.